Globally optimal trial design and risk sharing arrangements are key to avoiding opportunity costs of delay and enabling equitable, feasible and effective global vaccine research and implementation in current or future pandemics

• Autor Principal: Simon Eckermann (Author)
• Formato: Libro
• Publicado: Frontiers Media S.A., 2022-12-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

Global vaccination in the face of pandemics such as COVID-19 and new variants is a race against time. Avoiding the opportunity costs of delay and the associated health, social, and downstream economic impacts is a challenge and an imperative. Failures to address the global challenges posed by COVID-...